Characterization of demographics for those with post COVID-19 condition in Malaysia during Omicron wave
1. In a Malaysian cohort of adults affected with COVID-19, 3.4% were found to develop post COVID-19 condition. 2. Female ...
1. In a Malaysian cohort of adults affected with COVID-19, 3.4% were found to develop post COVID-19 condition. 2. Female ...
1. In this randomized-controlled trial, an mRNA-based vaccine was efficacious at preventing symptomatic infection with respiratory syncytial virus (RSV) involving ...
1. In this randomized controlled trial, rates of ventilator-associated pneumonia (VAP) were lower in ventilated patients using amikacin as compared ...
1. In this randomized controlled trial, ventilator-associated pneumonia (VAP) was prevented by employing inhaled amikacin in mechanically ventilated patients exceeding ...
1. In this randomized controlled trial, inhaled fluticasone furoate did not shorten the time to recovery for non-hospitalized patients with ...
1. 4-year event-free survival was significantly greater in I-SABR (77%) versus SABR alone (53%). 2. More patients in the I-SABR ...
1. In this cohort study, using generic versus brand-name fluticasone-salmeterol was associated with similar outcomes in chronic obstructive pulmonary disease ...
Adaptive Smoking Cessation Using Precessation Varenicline or Nicotine Patch: A Randomized Clinical Trial 1. This phase 2 double-blind placebo-controlled randomized ...
1. In postoperative patients randomized to receive either 30% FiO2 and 60% FiO2 via mechanical ventilation while under general anesthesia, ...
1. Median overall survival in the atezolizumab group was 10.3 months versus 9.2 months in the chemotherapy group. 2. Patients ...
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.